Pricing
  1. JP-listed companies
  2. SUSMED, Inc.
  3. Financials
  4. Net income margin (%)

SUSMED, Inc. (4263)

Market cap
¥16.6B
P/E ratio
Susmed develops digital therapeutic apps and IT platforms that help pharmaceutical companies and healthcare providers conduct clinical trials and analyze medical data more efficiently.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Jun 30, 2025-64.5-38.22%
Jun 30, 2024-104.3+990.93%
Jun 30, 2023-9.6-87.02%
Jun 30, 2022-73.7-69.34%
Jun 30, 2021-240.3-13.49%
Jun 30, 2020-277.8-93.56%
Jun 30, 2019-4,312.3-45.93%
Jun 30, 2018-7,975.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat